| Role and mechanism of action of sclerostin in bone J Delgado-Calle, AY Sato, T Bellido Bone 96, 29-37, 2017 | 447 | 2017 |
| Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone X Tu, J Delgado-Calle, KW Condon, M Maycas, H Zhang, N Carlesso, ... Proceedings of the National Academy of Sciences 112 (5), E478-E486, 2015 | 285 | 2015 |
| Bidirectional notch signaling and osteocyte-derived factors in the bone marrow microenvironment promote tumor cell proliferation and bone destruction in multiple myeloma J Delgado-Calle, J Anderson, MD Cregor, M Hiasa, JM Chirgwin, ... Cancer research 76 (5), 1089-1100, 2016 | 209 | 2016 |
| Genome‐wide profiling of bone reveals differentially methylated regions in osteoporosis and osteoarthritis J Delgado‐Calle, AF Fernández, J Sainz, MT Zarrabeitia, C Sañudo, ... Arthritis & Rheumatism 65 (1), 197-205, 2013 | 180 | 2013 |
| DNA methylation contributes to the regulation of sclerostin expression in human osteocytes J Delgado‐Calle, C Sañudo, A Bolado, AF Fernández, J Arozamena, ... Journal of Bone and Mineral Research 27 (4), 926-937, 2012 | 160 | 2012 |
| Role of DNA methylation in the regulation of the RANKL-OPG system in human bone J Delgado-Calle, C Sañudo, AF Fernández, R García-Renedo, MF Fraga, ... Epigenetics 7 (1), 83-91, 2012 | 151 | 2012 |
| H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells AF Fernández, GF Bayón, RG Urdinguio, EG Toraño, MG García, ... Genome research 25 (1), 27-40, 2015 | 145 | 2015 |
| The osteocyte as a signaling cell J Delgado-Calle, T Bellido Physiological reviews 102 (1), 379-410, 2022 | 140 | 2022 |
| Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineage J Delgado-Calle, C Sañudo, L Sánchez-Verde, RJ García-Renedo, ... Bone 49 (4), 830-838, 2011 | 131 | 2011 |
| Protection from glucocorticoid‐induced osteoporosis by anti‐catabolic signaling in the absence of Sost/Sclerostin AY Sato, M Cregor, J Delgado‐Calle, KW Condon, MR Allen, M Peacock, ... Journal of Bone and Mineral Research 31 (10), 1791-1802, 2016 | 123 | 2016 |
| Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth J Delgado-Calle, J Anderson, MD Cregor, KW Condon, SA Kuhstoss, ... Leukemia 31 (12), 2686-2694, 2017 | 119 | 2017 |
| Parathyroid Hormone Receptor Signaling Induces Bone Resorption in the Adult Skeleton by Directly Regulating the RANKL Gene in Osteocytes AN Ben-awadh, J Delgado-Calle, X Tu, K Kuhlenschmidt, MR Allen, ... Endocrinology 155 (8), 2797-2809, 2014 | 119 | 2014 |
| Control of bone anabolism in response to mechanical loading and PTH by distinct mechanisms downstream of the PTH receptor J Delgado‐Calle, X Tu, R Pacheco‐Costa, K McAndrews, R Edwards, ... Journal of Bone and Mineral Research 32 (3), 522-535, 2017 | 107 | 2017 |
| Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP‐1 crosstalk I Cárcamo‐Orive, A Gaztelumendi, J Delgado, N Tejados, A Dorronsoro, ... Journal of Bone and Mineral Research 25 (10), 2115-2125, 2010 | 91 | 2010 |
| Analysis of the bone microRNome in osteoporotic fractures P Garmilla-Ezquerra, C Sanudo, J Delgado-Calle, MI Pérez-Nuñez, ... Calcified tissue international 96, 30-37, 2015 | 83 | 2015 |
| Do epigenetic marks govern bone mass and homeostasis? J Delgado-Calle, P Garmilla, J A Riancho Current genomics 13 (3), 252-263, 2012 | 69 | 2012 |
| ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential I Cárcamo-Orive, N Tejados, J Delgado, A Gaztelumendi, D Otaegui, ... Experimental cell research 314 (8), 1777-1788, 2008 | 69 | 2008 |
| Role of osteocytes in multiple myeloma bone disease J Delgado-Calle, T Bellido, GD Roodman Current opinion in supportive and palliative care 8 (4), 407-413, 2014 | 68 | 2014 |
| Osteocytes and skeletal pathophysiology J Delgado-Calle, T Bellido Current molecular biology reports 1, 157-167, 2015 | 65 | 2015 |
| Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders C García-Ibarbia, J Delgado-Calle, I Casafont, J Velasco, J Arozamena, ... Gene 532 (2), 165-172, 2013 | 58 | 2013 |
